menu search

relmada and rel-1017: intriguing underlying efficacy in mdd ahead of eventful 2024

Phase 3 trial failures were due to abnormally high placebo responses driven by poor trial design, enrollment, and oversight. REL-1017's underlying eff...

October 13, 2023, 7:50 pm

relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023

Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...

October 11, 2023, 8:31 am

relmada (rlmd) up on positive data for anti-depressant candidate

Relmada's (RLMD) shares rise on long-term efficiency and safety data from the phase III study of its lead candidate REL-1017 to treat patients with ma...

September 21, 2023, 3:02 pm

relmada therapeutics: run up likely into phase 3 results, enhanced by possible interim readout

relmada Therapeutics has provided updates on its phase 3 program of esmethadone (REL-1017) as an adjunc...

September 1, 2023, 6:53 pm

Bragar eagel & squire, p.c. is investigating relmada, arrival, fmc, and viasat and encourages investors to contact the firm

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

July 27, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating waldencast, relmada, doubleverify, and castle and encourages investors to contact the firm

NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

July 22, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating shift4, waldencast, relmada, and doubleverify and encourages investors to contact the firm

NEW YORK, July 16, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

July 17, 2023, 12:40 am

Bragar eagel & squire, p.c. is investigating seagate, chegg, relmada, and doubleverify and encourages investors to contact the firm

NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

July 1, 2023, 6:43 am

Bragar eagel & squire, p.c. is investigating relmada, doubleverify, sanmina, and jinkosolar and encourages investors to contact the firm

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 26, 2023, 1:00 am

Rlmd investor news: rosen, recognized investor counsel, encourages relmada therapeutics, inc. investors with losses to inquire about securities class action investigation – rlmd

NEW YORK, June 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...

June 10, 2023, 8:59 pm

Bragar eagel & squire, p.c. is investigating relmada, bowlero, and integra and encourages investors to contact the firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 5, 2023, 1:00 am

Rosen, respected investor counsel, encourages relmada therapeutics, inc. investors to inquire about securities class action investigation – rlmd

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

June 3, 2023, 4:12 pm

Bragar eagel & squire, p.c. is investigating relmada, and sanmina and encourages investors to contact the firm

NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potenti...

May 20, 2023, 1:00 am

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of relmada therapeutics, inc. – rlmd

NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of re...

May 12, 2023, 11:46 pm

relmada therapeutics, inc. (rlmd) q1 2023 earnings call transcript

relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Comp...

May 12, 2023, 9:10 pm

relmada therapeutics to report first quarter 2023 financial results and host conference call and webcast on may 11, 2023

CORAL GABLES, Fla. , May 8, 2023 /PRNewswire/ -- relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stag...

May 8, 2023, 7:30 am

relmada therapeutics, inc. (rlmd) q4 2022 earnings call transcript

relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Co...

March 23, 2023, 10:27 pm

relmada therapeutics shares decline 40% on thursday

Shares of relmada Therapeutics Inc. RLMD, -0.95% tumbled about 40% in premarket trading on Thursday, th...

December 8, 2022, 8:39 am

relmada therapeutics, inc. (rlmd) q3 2022 earnings call transcript

relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET...

November 12, 2022, 8:33 am

relmada therapeutics, inc.'s (rlmd) ceo sergio traversa on q1 2022 results - earnings call transcript

relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Compa...

May 8, 2022, 11:27 am


Search within

Pages Search Results: